Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives

P Li, Z Liu - Chemical Society Reviews, 2024 - pubs.rsc.org
Aberrant glycans are a hallmark of cancer states. Notably, emerging evidence has
demonstrated that the diagnosis of cancers with tumour-specific glycan patterns holds great …

The gut-prostate axis: a new perspective of prostate cancer biology through the gut microbiome

K Fujita, M Matsushita, MA De Velasco, K Hatano… - Cancers, 2023 - mdpi.com
Simple Summary The gut microbiome plays important roles in the development of several
diseases. The gut microbiome is a dynamic system that is affected by several factors, such …

Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study

YB Wang, L Yang, YQ Deng, SY Yan, LS Luo… - Journal of translational …, 2022 - Springer
Background Obesity (waist circumference, body mass index (BMI)) and lifestyle factors
(dietary habits, smoking, alcohol drinking, Sedentary behavior) have been associated with …

Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis

Y Yang, J Sheng, S Hu, Y Cui, J **ao, W Yu… - Cell death & …, 2022 - nature.com
Benign prostatic hyperplasia (BPH) is the most common and progressive urological disease
in elderly men worldwide. Epidemiological studies have suggested that the speed of …

Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK/ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway …

Y Li, Y Zhou, D Liu, Z Wang, J Qiu, J Zhang… - Journal of Translational …, 2023 - Springer
Background Benign prostatic hyperplasia (BPH) is a common disease in elderly men, mainly
resulted from an imbalance between cell proliferation and death. Glutathione peroxidase 3 …

Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019

XF Xu, GX Liu, YS Guo, HY Zhu… - American Journal of …, 2021 - journals.sagepub.com
The objective of this study is to provide comprehensive and up-to-date estimates on the
disease burden of BPH in 204 countries and territories between 1990 and 2019. Data about …

Applications of microwaves in medicine

JC Chiao, C Li, J Lin, RH Caverly… - IEEE Journal of …, 2022 - ieeexplore.ieee.org
Advances and updates in medical applications utilizing microwave techniques and
technologies are reviewed in this paper. The article aims to provide an overview of enablers …

The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males

Y **ong, Y Zhang, X Li, F Qin, J Yuan - The Aging Male, 2020 - Taylor & Francis
Objective To investigate the prevalence and associated factors of lower urinary tract
symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in Chinese aging males …

Rezūm therapy for≥ 80‐mL benign prostatic enlargement: a large, multicentre cohort study

D Elterman, N Bhojani, C Vannabouathong… - BJU …, 2022 - Wiley Online Library
Objective To evaluate the efficacy and safety of Rezūm therapy in benign prostatic
hyperplasia (BPH) patients with prostates≥ 80 mL. Methods A prospective registry was …

[HTML][HTML] Association between metabolic syndrome and benign prostatic hyperplasia: The underlying molecular connection

X Fu, Y Wang, Y Lu, J Liu, H Li - Life Sciences, 2024 - Elsevier
Benign prostatic hyperplasia (BPH), a common cause of lower urinary tract symptoms
(LUTS), has been recently regarded as a metabolic disease. Metabolic syndrome (MetS) is a …